Augsburg Pharmaceuticals (Opc) Private Limited

Founded in 2014 and headquartered in Orissa, India.

2014 | Dhenkanal, Odisha (India) | Active
Last Updated: January 04, 2025

Augsburg Pharmaceuticals (Opc) Profile

Key Indicators

  • Authorised Capital ₹ 0.50 M
  • Paid Up Capital ₹ 0.10 M
  • Company Age 10 Year, 4 Months
  • Last Filing with ROC 31 Mar 2019
  • Revenue Growth 80.61%
  • Profit Growth 62.13%
  • Ebitda 86.96%
  • Net Worth -34.80%
  • Total Assets -13.57%

About Augsburg Pharmaceuticals (Opc)

Augsburg Pharmaceuticals (Opc) Private Limited (APOPL) is a Company incorporated in India on 25 September 2014 and has a history of Ten years and four months. Its registered office is in Dhenkanal, Odisha, India.

The Company is engaged in the Trading Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.

Swarnabhanu Das serves as a director at the Company.

Company Details

  • Location

    Dhenkanal, Odisha, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    -

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24232OR2014OPC018307

  • Company No.

    018307

  • Incorporation Date

    25 Sep 2014

  • Date of AGM

    28 Sep 2019

  • Date of Balance Sheet

    31 Mar 2019

  • Listing Status

    Unlisted

  • ROC Code

    Roc Cuttack

Industry

Trading

Who are the key members and board of directors at Augsburg Pharmaceuticals (Opc)?

Board Members (1)

Name Designation Appointment Date Status
Swarnabhanu Das Country flag representing In Director 25-Sep-2014 Current

Financial Performance of Augsburg Pharmaceuticals (Opc).

Augsburg Pharmaceuticals (Opc) Private Limited, for the financial year ended 2017, experienced significant growth in revenue, with a 80.61% increase. The company also saw a substantial improvement in profitability, with a 62.13% increase in profit. The company's net worth observed a substantial decline by a decrease of 34.8%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
80.61%
Revenue from Operations
80.61%
Total Assets
-13.57%
Profit or Loss
62.13%
Net Worth
-34.80%
EBITDA
86.96%

What is the Ownership and Shareholding Structure of Augsburg Pharmaceuticals (Opc)?

Unlock access to Augsburg Pharmaceuticals (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Augsburg Pharmaceuticals (Opc)?

Unlock and access historical data on people associated with Augsburg Pharmaceuticals (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Augsburg Pharmaceuticals (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Augsburg Pharmaceuticals (Opc)'s trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Augsburg Pharmaceuticals (Opc)

Recent activity within the organization

  • Annual General Meeting

    Augsburg Pharmaceuticals (Opc) Private Limited last Annual general meeting of members was held on 28 Sep 2019 as per latest MCA records.

    28 Sep 2019

  • Balance Sheet

    Augsburg Pharmaceuticals (Opc) Private Limited has filed its annual Financial statements for the year ended 31 Mar 2019 with Roc Cuttack.

    31 Mar 2019

  • Director Appointment

    Swarnabhanu Das was appointed as a Director was appointed as a Director on 25 Sep 2014 & has been associated with this company since 10 years 4 months .

    25 Sep 2014

  • Company Incorporation

    Augsburg Pharmaceuticals (Opc) Private Limited was registered on 25 Sep 2014 with Roc Cuttack & aged 10 years 4 months as per MCA records.

    25 Sep 2014

Frequently asked questions

  • Augsburg Pharmaceuticals (Opc) Private Limited was incorporated on 25 Sep 2014.

  • The authorized share capital of Augsburg Pharmaceuticals (Opc) Private Limited is ₹ 0.50 M and paid-up capital is ₹ 0.10 M.

  • Currently 1 director is associated with Augsburg Pharmaceuticals (Opc) Private Limited.

    • Swarnabhanu Das
  • As per Ministry of Corporate Affairs (Mca), the registered address of Augsburg Pharmaceuticals (Opc) Private Limited is Shyamacharnpur India, Dhenkanal, Orissa, 759001.

  • The corporate identification number (CIN) of Augsburg Pharmaceuticals (Opc) Private Limited is U24232OR2014OPC018307 and the company number is 018307 as per Ministry of Corporate Affairs (MCA).

  • According to the financial reports for the fiscal year 2017, the revenue trend for Augsburg Pharmaceuticals (Opc) Private Limited has risen by 80.61%.

  • The financial reports for the fiscal year 2017 indicates that The net worth of Augsburg Pharmaceuticals (Opc) Private Limited has experienced an downturn of -34.80%.

  • The most recent Balance Sheet for Augsburg Pharmaceuticals (Opc) Private Limited was filed with the ROC on 31 Mar 2019.